Patriot Scientific der Highflyer 2006
Ausschnitt:
Since 2005:
PTSC has shared in half of over $200M in license fees for the MMP.
PTSC has issued 8 cents per share in dividends.
PTSC has eliminated the warrant situation with S&L that was part of what was weighting the share price and increasing the O/S.
PTSC has acquired one small company in Holcom (sp?)
PTSC has settled minor litigation with Fish and others.
PTSC has successfully maneuvered its way through litigation with the J5, enticing 2 and part of a 3rd to defect and sign licenses, and forcing the other 2 and the remainder of the 3rd to follow suit before trial. This is a watershed moment for the company in that it validates it's patents in as much as companies praying for relief through non-infringement and/or a declaration of invalidity gave up their arguments and instead got out their checkbooks.
PTSC with some of the legwork done during the Markman process not to mention the strong portfolio of licenses substantially aided its case with the USPTO regarding 3 patent re-exams. Potentially by the settlement yesterday, it hastened the USPTO's action reaffriming the validity of its patents.
PTSC has planned for the future in outlining and working towards an M&A strategy geared towards additional predictable recurring revenue streams.
PTSC has utilized its profits from the licensing process to buyback a modest though substantial amount of shares, thus helping its position somewhat for M&A activities not to mention its efforts at moving to a better exchange.
PTSC has increased shareholder value by over 700% when you include the dividends, and experienced three times that appreciation on a temporary basis.
ALL of these items I outline substantially solidify the fundamentals of the company. There can be no argurment that it is in an almost infinitely better position than it was 2 years ago this time. Aside from what I personally think are some PR slip ups, and what others characterize much more strongly, PTSC has done little glaringly wrong. In fact, the only argument is that perhaps they could've done more, but we all have to admit that's our pretty arogant view of the activities and inner workings of a company we can only understand from the glimpses we get. We can't really know. Perhaps they've avoided HUGE unseen pitfals and salvaged what has been accomplished, rather than the viewpoints expressed here that belittle the accomplishments.
The bottom line is that regardless of how PR's have been handled, and what missteps they have experienced, none of that changes the facts listed above. None of it changes the fundamentals. None of detracts from the HUGE positives accomplished. That's the bottom line.
Summary Analysis
PTSC is undervalued compared to its Price of $0.66 per share, has below average safety, and is currently rated a Buy.
Detailed Analysis
Capital Appreciation
Value: Value is a measure of a stock's current worth. PTSC has a current Value of $1.25 per share. Therefore, it is undervalued compared to its Price of $0.66 per share. Value is computed from forecasted earnings per share, forecasted earnings growth, profitability, interest, and inflation rates. Value increases when earnings, earnings growth rate and profitability increase, and when interest and inflation rates decrease. VectorVest advocates the purchase of undervalued stocks. At some point in time, a stock's Price and Value always will converge.
RV (Relative Value): RV is an indicator of long-term price appreciation potential. PTSC has an RV of 1.52, which is excellent on a scale of 0.00 to 2.00. This indicator is far superior to a simple comparison of Price and Value because it is computed from an analysis of projected price appreciation three years out, AAA Corporate Bond Rates, and risk. RV solves the riddle of whether it is preferable to buy High growth, High P/E stocks, or Low growth, Low P/E stocks. VectorVest favors the purchase of stocks with RV ratings above 1.00.
RS (Relative Safety): RS is an indicator of risk. PTSC has an RS rating of 0.72, which is poor on a scale of 0.00 to 2.00. RS is computed from an analysis of the consistency and predictability of a company's financial performance, debt to equity ratio, sales volume, business longevity, price volatility and other factors. A stock with an RS rating greater than 1.00 is safer and more predictable than the average stock in the VectorVest database. VectorVest favors the purchase of stocks of companies with consistent, predictable financial performance.
RT (Relative Timing): RT is a fast, smart, accurate indicator of a stock's price trend. PTSC has a Relative Timing rating of 1.25, which is very good on a scale of 0.00 to 2.00. RT is computed from an analysis of the direction, magnitude, and dynamics of a stock's price movements over one day, one week, one quarter and one year time periods. Once a stock's price has established a strong trend, it is expected to continue in that trend for the short-term. If a trend dissipates, RT will gravitate toward 1.00. RT will explode from bottoms, dive from tops, and reflect changes in price momentum. VectorVest favors the purchase of stocks with RT ratings above 1.00.
VST (VST-Vector): VST is the master indicator for ranking every stock in the VectorVest database. PTSC has a VST rating of 1.19, which is good on a scale of 0.00 to 2.00. VST is computed from the square root of a weighted sum of the squares of RV, RS, and RT. Stocks with the highest VST ratings have the best combinations of Value, Safety and Timing. These are the stocks to own for above average, long-term capital appreciation. VectorVest advocates the purchase of safe, undervalued stocks rising in price.
Recommendation (REC): VectorVest gives a Buy, Sell, Hold recommendation on every stock, every day. PTSC has a Buy recommendation. REC reflects the cumulative effect of all the VectorVest parameters working together. These parameters are designed to help investors buy safe, undervalued stocks rising in price. They also help investors avoid or sell risky, overvalued stocks falling in price. VectorVest recommends that investors buy high VST-Vector, Buy-rated stocks in rising markets.
Stop (Stop-Price): Stop is an indicator of when to sell a long position or cover a short position. PTSC has a Stop of $0.57 per share. This is $0.09 below PTSC's current closing Price. A stock's Stop is computed from a 13 week moving average of its closing prices, and is fine-tuned according to the stock's fundamentals. High RV, high RS stocks have lower Stops, and low RV, low RS stocks have higher Stops. In the VectorVest system, a stock gets a 'B' or 'H' recommendation if its Price is above its Stop and an 'S' recommendation if its Price is below its Stop.
GRT (Earnings Growth Rate): GRT reflects a company's one to three year forecasted earnings growth rate in percent per year. PTSC has a forecasted Earnings Growth Rate of 32.00%, which VectorVest considers to be excellent. GRT is computed from historical, current and forecasted earnings data. It is updated each week for every stock in the VectorVest database. GRT often foretells a stock's future price trend. If a stock's GRT trend is upward, the stock's price will likely rise. If GRT is trending downward, the stock's Price will probably fall. VectorVest favors the purchase of stocks whose GRT is rising and is greater than the sum of current inflation and interest rates, (10.17%).
EPS (Earnings per Share): EPS stands for leading 12 months Earnings Per Share. PTSC has a forecasted EPS of $0.08 per share. VectorVest determines this forecast from a combination of recent earnings performance and traditional fiscal and/or calendar year earnings forecasts.
P/E (Price to Earnings Ratio): P/E is a popular measure of stock valuation which shows the dollars required to buy one dollar of earnings. PTSC has a P/E of 8.25. This ratio may be deemed to be high or low depending upon your frame of reference. The average P/E of all the stocks in the VectorVest database is 30.19. P/E is computed daily using the formula: P/E = Price/EPS.
EY (Earnings Yield): EY reflects earnings per share as a percent of Price. EY is related to P/E via the formula, EY = 100 / (P/E), and may be used in place of P/E as a measure of valuation. EY has the advantages that it is always determinate and can reflect negative earnings. PTSC has an EY of 12.12 percent. This is above the current average of 3.32% for all the stocks in the VectorVest database. EY equals 100 x (EPS/Price).
GPE (Growth to P/E Ratio): GPE is another popular measure of stock valuation. It compares earnings growth rate to P/E ratio. PTSC has a GPE rating of 3.88. High growth stocks are believed to be able to justify high P/E ratios. A stock is commonly considered to be undervalued when GPE is greater than 1.00 and overvalued when GPE is below 1.00. Unfortunately, this rule of thumb does not take into account the effect of interest rates on P/E ratios. The operative GPE ratio of 1.00 is valid when and only when interest rates equal 10%. With long-term interest rates currently at 5.87%, the operative GPE ratio is 0.34. Therefore, PTSC may be considered to be undervalued.
Dividend Information
DIV (Dividend): VectorVest reports annual, regular, cash dividends as indicated by the most recent payments. Special distributions, one-time payments, stock dividends, etc., are not generally included in DIV. PTSC pays an annual dividend of $0.02 per share.
DY (Dividend Yield): DY reflects dividend per share as a percent of Price. PTSC has a Dividend Yield of 3%. This is above the current average of 1.3% for all the stocks in the VectorVest database. DY equals 100 x (DIV/Price). It is useful to compare DY with EY. If DY is not significantly lower than EY, the dividend payment may be in jeopardy.
DS (Dividend Safety): DS is an indicator of the assurance that regular cash dividends will be declared and paid at current or at higher rates for the foreseeable future. PTSC has a Dividend Safety of 48 , which is poor on a scale of 0 to 99. Stocks with DS values above 75 typically have RS values well above 1.00 and EY levels that are much higher than DY.
DG (Dividend Growth Rate): Dividend Growth is a subtle yet important indicator of a company's financial performance. It also provides some insight into the board's outlook on the company's ability to increase earnings. PTSC has a Dividend Growth of -11% This is below to the current average of 3% for all the stocks in the VectorVest database.
YSG (YSG-Vector): YSG is an indicator which combines DIV, DY and DG into a single value, and allows direct comparison of all dividend-paying stocks in the database. PTSC has a YSG rating of 0.75, which is poor on a scale of 0.00 to 2.00. Stocks with the highest YSG values have the best combinations of Dividend Yield, Safety and Growth. These are the stocks to buy for above average current income and long-term growth.
Price-Volume Data
Price: PTSC closed on 12/19/2007 at $0.66 per share
Open: PTSC opened trading at a price of $0.77 per share on 12/19/2007.
High: PTSC traded at a High price of $0.78 per share on 12/19/2007.
Low: PTSC traded at a Low price of $0.62 per share on 12/19/2007
Close: PTSC closed trading at price $0.66 per share on 12/19/2007. (Close is also called Price in the VectorVest system)
Range: Range reflects the difference between the High and Low prices for the day. PTSC traded with a range of $0.16 per share on 12/19/2007.
$Change: PTSC closed down 0.14 from the prior day's closing Price.
%PRC: PTSC's Price changed -17.50% from the prior day's closing price.
Volume: PTSC traded 7,051,771 shares on 12/19/2007.
AvgVol: AvgVol is the 50 day moving average of daily volume as computed by VectorVest. PTSC has an AvgVol of 1,498,800 shares traded per day.
%Vol: %Vol reflects the percent change in today's trading volume as compared to the AvgVol. %Vol equals ((Volume - AvgVol) / AvgVol ) * 100. PTSC had a %Vol of 370.49% on 12/19/2007
CI (Comfort Index): CI is an indicator which reflects a stock's ability to resist severe and/or lengthy price declines. PTSC has a CI rating of 0.51, which is poor on a scale of 0.00 to 2.00. CI is quite different from RS in that it is based solely upon a stock's long-term price history. VectorVest advocates the purchase of high CI stocks.
Sales / Market Capitalization Information
Sales: PTSC has annual sales of $
Sales Growth: Sales Growth is the Sales Growth Rate in percent over the last 12 months. PTSC has a Sales Growth of 999.00% per year. This is excellent. Sales Growth is updated each week for every stock. It is often useful to compare Sales Growth to Earnings Growth to gain an insight into a company's operations.
Sales Per Share (SPS): PTSC has annual sales of $0.00 per share. SPS can be used as a measure of valuation when comparing stocks within an Industry Group.
Price to Sales Ratio (P/S): PTSC has a P/S of 403.50. This ratio is also used as a measure of valuation. Here, too, it is useful when comparing stocks within an Industry Group.
Shares: PTSC has 391,000,000 shares of stock outstanding.
Market Capitalization: PTSC has a Market Capitalization of $258,000,000. Market Capitalization is calculated by multiplying price times shares outstanding.
Business: Patriot Scntfc, (PTSC) Patriot Scientific Corporation engages in the development, marketing, and sale of microprocessors, technology for microprocessors, and complementary products in the United States. Its products are used in a range of embedded control applications.
Business Sector: PTSC has been assigned to the Telecomm Business Sector. VectorVest classifies stocks into over 200 Industry Groups and 40 Business Sectors.
Industry Group: PTSC has been assigned to the Telecomm (Equipment) Industry Group. VectorVest classifies stocks into over 200 Industry Groups and 40 Business Sectors.
von PTSC zumindest kritisch hinterfragen, wie dieser Shareholder, dessen Mail an die Firma stimme ich voll und ganz zu:
********************************
http://www.agoracom.com/ir/patriot/messages/671236#message
The first step in my drive for my clarity from our company. This was sent
Posted by: EDIGOKIE on December 20, 2007 09:48AM
To whom it may concern, My name is xxxxx. I have been a Patriot shareholder since 1999 and currently own in excess of xxxxxxx shares. I have faith in the technology contained in the MMP and in our current CEO. I believe Mr. Turley has the tools to take this company and its' investors to the next level and beyond. That said, I, like a great many shareholders, am somewhat dismayed at the total lack of visibility this company provides its' shareholders. A mushroom makes a very poor conversation partner. It is, therefore, difficult for us to actively promote our company and technology to potential investors. We as investors constantly receive fire from all quarters. Unfortunately we have very few answers and only questions with which to respond. Public companies must, at a minimum, meet SEC requirements and I am confident Patriot will meet those minimum requirements. To do otherwise would not be prudent and would surely invite detailed inspection and oversight from the SEC. These reporting requirements, however, constitute the "minimum" reporting requirements, Shareholders are worthy of more than the minimum but will most certainly be watching to ensure those minimum requirements are met. In addition to the lack of visibility provided by company press releases I am also concerned by some of the vagaries of Patriot's stock trading patterns. I would like Mr. Turley to address this issue with an appropriate form of public discourse. Angry, confused shareholders can create a myriad of problems for Mr. Turley, our Board. and other shareholders. I am relatively certain no one at Patriot wants to spend their time answering inquiries from or, even worse, being involved in an SEC investigation. Enough shareholder complaints to the SEC could trigger just such an intrusion from that organization and would trigger even more uncertainty and doubt. These results are concommitant with poor shareholder information and are, in fact, an almost predictable outcome. I respectfully request that you forward this missive to Mr. Turley and that he provide more clarity and long range perspective to shareholders. Regardless of the NDA contained in the recent settlement, Mr. Turley can do a better job providing insight into where he intends to take this company as well as its' current status. Failure to do so is not in the best interest of our company. Thank you for your consideration.
Respectfully, xxxxx |
Optionen
| Boardmail an "Matzelbub" |
Wertpapier: Patriot Scientific |
Es gibt m.E. zwei Szenarien:
1.
Die Höhe der Zahlungen sind entsprechend hoch genug. Durch den Passus haben die Japaner ihr Gesicht zunächst gewahrt. Gleichwohl kommen die Zahlen ans Licht. Die Zeit bis April lässt zumindestens "Gras über die Sache wachsen". Bei einer Veröffentlichung hatte dies den Kurs der J´s sehr geschadet.
Möglich ist, dass PTSC gesagt hat, wenn ihr noch eine Schippe drauflegt, vereinbaren wir zunächst Stillschweigen und verbieten den Handel für die Angestellten, da sie sonst super Gewinne machen würden.
2.
Die Höhe der Zahlungen sind gering.
Dann macht das Verschweigen m.E. keinen Sinn. Die J´s hätten gesagt, wir haben in dem Streit Peanuts bezahlt, was ihrem Unternehmen an der Börse vermutlich gut getan hätte.
In dem Fall wäre der Kurs von PTSC eh in den Keller gerauscht und ein Verbot des Insiderhandels ist auch Quatsch, da die Angestellten eh im April große Verluste machen würden.
Aus meiner Sicht sehe ich die 1. Alternative als gegeben an.
Schade ist es allemal was mit dem Kurs passiert, aber wir können es nicht ändern.
die J's haben Peanuts gezahlt (siehe Sony) und TPL/PTSC verlangten Stillschweigen, um ihre Verhandlungsbasis mit den durch den Vergleich unter Druck geratenen, potentiellen Lizenznehmern zu verbessern.
Egal wie, solange keiner weiss, was an Umsätzen reinkommt durch die Patente in den nächsten Jahren, haben Trader leichtes Spiel und die institutionellen Anleger bleiben weg.
Ich bin es leid, ständig spekulieren zu müssen, beim nächsten Hype steige ich aus.
Optionen
| Boardmail an "Matzelbub" |
Wertpapier: Patriot Scientific |
Wir werden es eh erst im April erfahren. Alles ist möglich.
Es ist doch wirklich ein Witz. Warum macht man nicht einfach reinen Tisch. So ist es, seht her und gut ist.
Mann, Mann, Mann.
Ich überlege echt auch beim nächsten Hype rauszugehen und vielleicht im April wieder einzusteigen.
SUMMARY
After the announcement on Monday, December 18, 2007, Patriot Scientific's common stock popped up immediately to an intra-day high
of $0.94 per share before closing the day at $0.80 per share. Since then, the stock has faded to the $0.60 per share range. While the
settlement news is certainly positive for Patriot Scientific and bodes well for future settlements with possible infringers, we believe the
stock price reflects the fact that the terms of the settlement are confidential and investors have to speculate in the dark about the
amounts involved. As we have said before unfortunately, the financial proceeds information for licenses, and now these settlements, is
not available until Patriot Scientific's quarterly results are released. The financial data for the five licenses granted in the quarter ended
November 30, 2007, will not be known until mid-January 2008, and the three latest licenses' financial data and the money from the
settlements will not be available until after the release of results for the quarter ended February 28, 2008. Further, the stock may be
buffeted by tax selling and short-term traders taking profits.
We reiterate our Speculative Buy Rating and our $0.92 price per share target for Patriot Scientific.
Optionen
| Boardmail an "Matzelbub" |
Wertpapier: Patriot Scientific |
UNITED STATES DISTRICT COURT EASTERN DISTRICT OF TEXAS MARSHALL DIVISION DIVISION
Technology Properties Limited and Patriot
Scientific Corporation,
Plaintiffs,
v.
Matsushita Electrical Industrial Co., Ltd.,
Panasonic Corporation of North America, NC
Americas Corporation, NEC Electronics
America, Inc., Toshiba Corporation, Toshiba
America, Inc., Toshiba America Electronic
Components, Inc., Toshiba America
Information Systems, Inc. and Toshiba America
Consumer Products, LLD,
Defendants.
JURY DEMANDED
ORDER FOR DISMISSAL
The Parties, Plaintiffs Technology Properties Limited ("TPL") and Patriot Scientific Corporation ("Patriot") and Defendants Matsushita Electric Industrial Co., Ltd. ("Matsushita"), Panasonic Corporation ofNorth America ("Panasonic"), NC Americas Corporation ("NCA"), Toshiba Corporation ("Toshiba"), Toshiba America, Inc. ("TAl"), Toshiba America Electronic Components, Inc. ("TAEC"), Toshiba America Information Systems, Inc. ("TAIS") and Toshiba America Consumer Products, LLC ("TACP"), have resolved the issues between them. For good cause, this Court hereby approves the Stipulation for Dismissal and Orders that the remaining claims among these parties shall be dismissed, with each party bearing its own costs and attorneys' fees. Plaintiffs' claims are hereby dismissed with prejudice and Defendant TAEC's counterclaims are dismissed without prejudice. The Court expressly retains jurisdiction for purposes of enforcing the Agreement and the Memorandum of Understanding, the terms of which are hereby incorporated by reference. The Agreement, which incorporates the Memorandum of Understanding, is attached hereto, under seal, as Exhibit A.
Signed By Judge Ward
Optionen
| Boardmail an "Matzelbub" |
Wertpapier: Patriot Scientific |
Was hat es damit auf sich, die Vereinbarungen und die Absichtserklärung aus dem Settlement werden weiterhin der Kontrolle des Gerichtes unterliegen ? Dies bedeutet, dass es sich bei dem Settlement nicht um eine einmalige Zahlung der Beklagten handelt, denn in diesem Fall wäre eine Überwachung durch das Gericht nicht nötig. Es muss sich daher um eine komplexere Form von Geschäftsvereinbarung zwischen den Parteien handeln, wobei ich hoffe, dass zumindest ein Teil davon als beträchtliche Summe in dem Q-Bericht im April wieder auftauchen wird. Es könnte aber auch sein, dass zwar ein stattlicher Betrag erstritten wurde, dieser aber über einen langen Zeitraum -in Kleckerbeträge gestückelt- zu zahlen ist. Dann werden wir wieder einmal lange Gesichter im April sehen, wenn die Zahlen des laufenden Quartals fällig sind.
Ich befürchte, dass PTSC auf diese Art und Weise (Verschleierung der Details über bereits erzielte und zukünftig zu erwartende Lizenzeinnahmen) niemals den Sprung an eine seriöse Börse schaffen wird, denn dazu braucht es institutionelle Investoren, die wissen wollen, was Sache ist.
Optionen
| Boardmail an "Matzelbub" |
Wertpapier: Patriot Scientific |
CUPERTINO, Calif. – Dec. 21, 2007 – Alliacense today announced that Verigy Ltd. has purchased a Moore Microprocessor Patent™ (MMP) Portfolio license from The TPL Group. Verigy is a premier automated test equipment company with two decades of heritage in semiconductor test.
“This agreement is in the best interests of Verigy, its shareholders and customers because it removes the possibility of supply chain disruptions,” said Mike Davis, Senior Vice President, Licensing for Alliacense. “A strong wave of interest from companies selling microprocessor-based products has propelled the MMP Portfolio Licensing Program to the next level, as over 45% of license signings have followed the favorable Markman ruling issued earlier this summer.”
The sweeping scope of applications using MMP Portfolio design techniques continues to encourage the world’s leading manufacturers of end user products from around the globe to become MMP Portfolio licensees. Since January 2006 over 30 global companies from the US, Europe, Japan, Korea and Taiwan have purchased MMP Portfolio licenses.
The MMP Portfolio patents, filed by The TPL Group in the 1980s, cover techniques that enable higher performance and lower cost designs, and are fundamental to consumer and commercial digital systems ranging from DVD players, cell phones and portable music players to communications infrastructure, medical equipment -- and automobiles which today have dozens of microprocessor-based key features and benefits.
About the MMP Portfolio
The Moore Microprocessor Patent Portfolio contains intellectual property that is jointly owned by the privately-held TPL Group and publicly-held Patriot Scientific Corporation (OTCBB: PTSC). The MMP Portfolio includes seven U.S. patents as well as their European and Japanese counterparts. It is widely recognized that the MMP Portfolio protects fundamental technology used in microprocessors, microcontrollers, digital signal processors (DSPs), embedded processors and system-on-chip (SoC) devices. Manufacturers of microprocessor-based products can learn more about how to participate in the MMP Portfolio Licensing Program by contacting: mmp-licensing@alliacense.com.
About Verigy
Verigy designs, develops, manufactures, sells and services advanced test systems and solutions for the memory and system-on-chip segments of the semiconductor industry. Verigy’s scalable platform systems are used by leading semiconductor companies worldwide in design validation, characterization, and high volume manufacturing test. Formerly part of Agilent Technologies, the company began doing business as Verigy on June 1, 2006, and completed its initial public offering on June 13, 2006. Information about Verigy can be found at www.verigy.com.
About Alliacense
Alliacense is a TPL Group Enterprise executing best-in-class design and implementation of Intellectual Property (IP) licensing programs. As a cadre of IP licensing strategists, technology experts, and experienced business development/management executives, Alliacense focuses on expanding the awareness and value of TPL’s IP portfolios. Founded in 1988, The TPL Group has emerged as a coalition of high technology enterprises involved in the development, management and commercialization of proprietary product technologies as well as the design, manufacture and sales of proprietary products based on those technologies and corresponding IP assets. For more information, visit www.alliacense.com.
Verigy Purchases Microprocessor Patent Portfolio License
Maker of Test Equipment a Recent Spin-off from Agilent
CARLSBAD, Calif.--(BUSINESS WIRE)--Patriot Scientific Corporation (OTCBB:PTSC) announced today that Verigy Ltd. has purchased a Moore Microprocessor Patent™ (MMP) Portfolio license. Verigy is a premier automated test equipment (ATE) company with two decades of heritage in semiconductor testing.
“Verigy occupies an important position in the overall semiconductor industry,” said Jim Turley, president and CEO of Patriot Scientific. “As chips get more complex, it becomes harder to verify they work properly, and Verigy’s 1500+ employees make sure that our industry runs smoothly.”
“This agreement is in the best interests of Verigy, its shareholders and customers because it removes the possibility of supply-chain disruptions,” said Mike Davis, senior vice president, Licensing for Alliacense, Patriot Scientific’s licensing partner. “A strong wave of interest from companies selling microprocessor-based products has propelled the MMP Portfolio licensing program to the next level, as over 45% of license signings have followed the favorable Markman ruling issued earlier this summer.”
The sweeping scope of applications using MMP Portfolio design techniques continues to encourage the world’s leading manufacturers of end user products from around the globe to become MMP Portfolio licensees. Since January 2006 over 30 global companies from the US, Europe, Japan, Korea and Taiwan have purchased MMP Portfolio licenses.
About Verigy
Verigy designs, develops, manufactures, sells and services advanced test systems and solutions for the memory and system-on-chip (SoC) segments of the semiconductor industry. Verigy’s scalable platform systems are used by leading semiconductor companies worldwide in design validation, characterization and high-volume manufacturing testing. Formerly part of Agilent Technologies, the company began doing business as Verigy on June 1, 2006, and completed its initial public offering on June 13, 2006. Information about Verigy can be found at http://www.verigy.com.
About Patriot Scientific
Patriot Scientific is a leading intellectual-property licensing company that develops, markets, and enables innovative technologies that satisfy the demands of fast-growing markets for wireless devices, smart cards, home appliances, network gateways, set-top boxes, entertainment technology, automotive telematics, biomedical devices, industrial controllers and more. Headquartered in Carlsbad, Calif., information about the company can be found at http://www.ptsc.com.
An investment profile on Patriot Scientific may be found at http://www.hawkassociates.com/ptscprofile.aspx. Copies of Patriot Scientific press releases, current price quotes, stock charts and other valuable information for investors may be found at http://www.hawkassociates.com and http://www.americanmicrocaps.com. To receive free e-mail notification of future releases for Patriot Scientific, sign up at http://www.hawkassociates.com/email.aspx.
About the MMP Portfolio
The Moore Microprocessor PatentTM Portfolio contains intellectual property that is jointly owned by the privately held TPL Group and publicly held Patriot Scientific Corporation (OTCBB:PTSC). The portfolio includes seven U.S. patents as well as their European and Japanese counterparts. The jointly owned patents protect fundamental technology used in the design of microprocessors, microcontrollers, digital signal processors (DSPs), embedded microprocessors, and system-on-chip (SoC) devices. Manufacturers of microprocessor-based products can learn more about how to participate in the MMP Portfolio Licensing Program by contacting: mmp-licensing@alliacense.com.
About Alliacense
Alliacense is a TPL Group Enterprise executing best-in-class design and implementation of Intellectual Property (IP) licensing programs. As a cadre of IP licensing strategists, technology experts, and experienced business development/management executives, Alliacense focuses on expanding the awareness and value of TPL’s IP portfolios. Founded in 1988, The TPL Group has emerged as a coalition of high technology enterprises involved in the development, management and commercialization of proprietary product technologies as well as the design, manufacture and sales of proprietary products based on those technologies and corresponding IP assets. For more information, visit http://www.alliacense.com.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: Statements in this news release looking forward in time involve risks and uncertainties, including the risks associated with the effect of changing economic conditions, trends in the products markets, variations in the company's cash flow, market acceptance risks, patent litigation, technical development risks, seasonality and other risk factors detailed in the company's Securities and Exchange Commission filings.
Moore Microprocessor Patent (MMP) and Alliacense are trademarks of Technology Properties Limited (TPL). PTSC is a trademark of Patriot Scientific Corporation. All other trademarks belong to their respective owners.
Contacts
Patriot Scientific Corporation, Carlsbad
Media Relations
The Hoffman Agency
John Radewagen, Vice President, Corporate Communications
408-975-3005
408-219-9199 (mobile)
jradewagen@hoffman.com
or
Patriot Scientific Investor Relations
Hawk Associates
Frank Hawkins or Ken AuYeung, 305-451-1888
or
TPL/Alliacense Media Relations
Shawn Clark, 408-446-4222
shawnc@tplgroup.net
Optionen
| Boardmail an "Matzelbub" |
Wertpapier: Patriot Scientific |
Optionen
| Boardmail an "Matzelbub" |
Wertpapier: Patriot Scientific |
http://www.cheesebuerger.de/images/smilie/musik/f045.gif
Optionen
| Boardmail an "Gilbertus" |
Wertpapier: Patriot Scientific |
Na,steigt nur aus!
Und mit jedem neuen Lizenznehmer werde ich an Euch denken,lol!
Fakt ist, seit dem ich in diesem Laden investiert bin, ging es stetig mit der Firma bergauf. (Ich meine die Firma nicht den Aktienkurs.)
Und wie Nassie es mal auf den Punkt brachte, ich kenne im Moment kein besseres Investment.
Frohe Weihnachten,
Abenteurer
"Milliönchen" kommen und gehn, da bin ich eher der Mittelständler:
Auf solidem Fundament muss man das Häusle bauen!
Flirty, Mensch da bist Du ja schon so richtig zum Market Maker mutiert. An meine 3.487.127 Aktien reicht das aber immernoch nicht ran. Du solltest unbedingt noch so eine Tanznummer wie Gilbertus drauflegen um nicht ganz disqualifiziert zu werden.
Grüße Abenteurer
Jeder hat hier seine Strategie und seine Ziele.